Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Standard practice limits cycles to 4 to 6 weeks, followed by equal or longer time off
Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3/Nrf2 axis
Take 2 capsules 1 to 3 times daily
E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P2463 - ESOC25-203 SECONDARY PREVENTION IN STROKE AND TIA PATIENTS UNDER DOACS IN NORTHEREN ISRAEL: A CASE-BY-CASE APPROACH Adi Shemesh 1 , Sivan Bloch 1 1 Carmel medical center, Haifa, Israel Background and Aims: Patients with atrial fibrillation (AF) are at increased risk for CVA & TIA 1 , and those who suffer a breakthrough CVA/TIA while on direct oral anticoagulants (DOACs) are challenging to treat 15
Phc hi da h tn,khc phc np nhn, da kh rp v khng u mu
US$ 27.62
US$ 23.81
US$ 22.00
US$ 27.22
US$ 28.93
US$ 27.77
US$ 26.28